SYNTHESIS OF 1α,25-DIHYDROXY-2β-(3-HYDROXYPROPOXY)VITAMIN D3 (ELDECALCITOL) AND RELATED COMPOUNDS BY THE TROST CONVERGENT METHODOLOGY

被引：8

作者：

Kubodera, Noboru ^{[1
]}

Hatakeyama, Susumi ^{[2
]}

机构：

[1] Chugai Pharmaceut Co Ltd, Chuo Ku, Tokyo 1038324, Japan

[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan

来源：

HETEROCYCLES | 2009年 / 79卷

关键词：

Active Vitamin D-3 Analog; Calcitriol; 1; alpha; 25-Dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3; Eldecalcitol; Trost Convergent Methodology; VITAMIN-D ANALOGS; BONE-MINERAL LOSS; PARATHYROID-HORMONE SECRETION; OVARIECTOMIZED RATS; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; OSTEOPOROTIC PATIENTS; BIOLOGICAL EVALUATION; POTENT SUPPRESSOR; D-RIBONOLACTONE; D METABOLITES;

D O I：

10.3987/REV-08-SR(D)3

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Using Trost convergent methodology, the synthesis of 1 alpha,25-dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3 (eldecalcitol) for the improved and industrial scale production and related putative metabolites of eldecalcitol is summarized. In addition, A-ring diastereomers at the 1- and 3-positions of eldecalcitol are described. The synthesis centers on a key palladium-catalyzed alkylative cyclization and coupling of ene-ynes that constitute the A-ring fragment to bromomethylenes comprising the C/D-ring fragment which affords the requisite triene framework of vitamin D-3 analogs.

引用

页码：145 / 162

页数：18

共 50 条

[21] ED-71, 1α,25-dihydroxy-2β(3-hydroxypropoxy)vitamin D3 is a potent inhibitor of bone resorption in aged estrogen-deficient rats.
Takeda, S
Uchiyama, Y
Higuchi, Y
Shiraishi, A
Tsunemi, K
Kubota, N
Sato, K
Saito, H
Takahashi, F
Makishima, F
Kubodera, N
Ikeda, K
Ogata, E
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S323 - S323
[22] 1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71) does not disturb fracture healing process in rat's femoral fracture model.
Mori, S
Cao, Y
Miyamoto, K
Iwata, K
Mahiba, T
Akiyama, T
Komatsubara, S
Manabe, T
Norimatsu, H
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S323 - S323
[23] Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-Epi-1alfa,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-Epi-ED-71]
Hatakeyama, Susumi
Yoshino, Madoka
Eto, Kohei Kohei
Takahashi, Keisuke
Ishihara, Jun
Ono, Yoshiyuki
Saito, Hitoshi
Kubodera, Noboru
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[24] Synthesis of All Possible A-ring Diastereomers at the 1-and 3-Positions of 1α,25-Dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71) Using C2-Symmetrical Epoxide as a Common Starting Material
Kubodera, Noboru
Hatakeyama, Susumi
ANTICANCER RESEARCH, 2009, 29 (09) : 3571 - 3578
[25] 2α-(3-hydroxypropyl)- and 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 accessible to vitamin D receptor mutant related to hereditary vitamin D-resistant rickets
Kittaka, A
Kurihara, M
Peleg, S
Suhara, Y
Takayama, H
CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (03) : 357 - 358
[26] Bone histomorphological examination reveals ED-71, 1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3, and human PTH(1-34) activate bone formation in a different way in aged ovariectomized rats.
Tsunemi, K
Takeda, S
Sugita, A
Takahashi, F
Saito, H
Kubodera, N
Makishima, F
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S463 - S463
[27] Synthesis and Biological Activity of 1α,2α,25-Trihydroxyvitamin D3: Active Metabolite of 2α-(3-Hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by Human CYP3A4
Takano, Masashi
Ohya, Saori
Yasuda, Kaori
Nishikawa, Miyu
Takeuchi, Akiko
Sawada, Daisuke
Sakaki, Toshiyuki
Kittaka, Atsushi
CHEMICAL & PHARMACEUTICAL BULLETIN, 2014, 62 (02) : 182 - 184
[28] REGULATORY ACTIVITIES OF 2-BETA-(3-HYDROXYPROPOXY)-1-ALPHA,25-DIHYDROXY-VITAMIN-D3, A NOVEL SYNTHETIC VITAMIN-D3 DERIVATIVE, ON CALCIUM-METABOLISM
OKANO, T
TSUGAWA, N
MASUDA, S
TAKEUCHI, A
KOBAYASHI, T
TAKITA, Y
NISHII, Y
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (03) : 1444 - 1449
[29] An efficient convergent synthesis of 1α,25-dihydroxy-3-epi-vitamin D2
Sigueeiro, Rita
Otero, Rocio
Gonzalez-Berdullas, Patricia
Maestro, Miguel
Mourino, Antonio
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 148 : 31 - 33
[30] Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
Takeda, Satoshi
Smith, Susan Y.
Tamura, Tatsuya
Saito, Hitoshi
Takahashi, Fumiaki
Samadfam, Rana
Haile, Solomon
Doyle, Nancy
Endo, Koichi
CALCIFIED TISSUE INTERNATIONAL, 2015, 96 (01) : 45 - 55

← 1 2 3 4 5 →